In our screening of HNSCC cell lines, we observed that every cell line expressed different levels of RIP1, RIP3, and MLKL, indicating that the insensitivity to TSZ treatment is not due to the expression level of necroptotic components. Here, RIPK1 is linked to head and neck squamous cell carcinoma.